Lipid Measures and Cardiovascular Disease Prediction
Traditional lipid measures are the cornerstone of risk assessment and treatment goals in cardiovascular prevention. Whereas the association between total, LDL-, HDL-cholesterol and cardiovascular disease risk has been generally acknowledged, the rather poor capacity to distinguish between patients w...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
IOS Press
2009
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833241/ |
| id |
pubmed-3833241 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-38332412013-12-10 Lipid Measures and Cardiovascular Disease Prediction van Wijk, Diederik F. Stroes, Erik S. G. Kastelein, John J. P. Other Traditional lipid measures are the cornerstone of risk assessment and treatment goals in cardiovascular prevention. Whereas the association between total, LDL-, HDL-cholesterol and cardiovascular disease risk has been generally acknowledged, the rather poor capacity to distinguish between patients who will and those who will not develop cardiovascular disease has prompted the search for further refinement of these traditional measures. A thorough understanding of lipid metabolism is mandatory to understand recent developments in this area. After a brief overview of lipid metabolism we will discuss the epidemiological data of total, LDL- and HDL-cholesterol and focus on recent advances in measurements of these lipoproteins. In addition we will discuss the role of triglycerides and the apolipoprotein B–A-I ratio on the incidence of cardiovascular disease. IOS Press 2009 2009-09-21 /pmc/articles/PMC3833241/ /pubmed/19773610 http://dx.doi.org/10.3233/DMA-2009-0636 Text en Copyright © 2009 Hindawi Publishing Corporation. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
van Wijk, Diederik F. Stroes, Erik S. G. Kastelein, John J. P. |
| spellingShingle |
van Wijk, Diederik F. Stroes, Erik S. G. Kastelein, John J. P. Lipid Measures and Cardiovascular Disease Prediction |
| author_facet |
van Wijk, Diederik F. Stroes, Erik S. G. Kastelein, John J. P. |
| author_sort |
van Wijk, Diederik F. |
| title |
Lipid Measures and Cardiovascular Disease Prediction |
| title_short |
Lipid Measures and Cardiovascular Disease Prediction |
| title_full |
Lipid Measures and Cardiovascular Disease Prediction |
| title_fullStr |
Lipid Measures and Cardiovascular Disease Prediction |
| title_full_unstemmed |
Lipid Measures and Cardiovascular Disease Prediction |
| title_sort |
lipid measures and cardiovascular disease prediction |
| description |
Traditional lipid measures are the cornerstone of risk assessment and treatment goals in cardiovascular prevention. Whereas the association between total, LDL-, HDL-cholesterol and cardiovascular disease risk has been generally acknowledged, the rather poor capacity to distinguish between patients who will and those who will not develop cardiovascular disease has prompted the search for further refinement of these traditional measures. A thorough understanding of lipid metabolism is mandatory to understand recent developments in this area. After a brief overview of lipid metabolism we will discuss the epidemiological data of total, LDL- and HDL-cholesterol and focus on recent advances in measurements of these lipoproteins. In addition we will discuss the role of triglycerides and the apolipoprotein B–A-I ratio on the incidence of cardiovascular disease. |
| publisher |
IOS Press |
| publishDate |
2009 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833241/ |
| _version_ |
1612028402647171072 |